34988-34-6

• 常用中文名：N-[(3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ylidene)amino]-4-methyl-benzenesulfonamide
• 常用英文名：N-[(3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ylidene)amino]-4-methyl-benzenesulfonamide
• CAS号：34988-34-6
• 分子式：C₂₆H₃₆N₂O₃S
• 分子量：456.64100
• 发布时间：2016-02-08 10:38:05
• 更新时间：2024-07-21 11:39:10

名称

• 英文名: N'-(3-hydroxy-10,13-dimethyl-3,4,7,8,9,11,12,13,15,16-decahydro-1H-cyclopenta[a]phenanthren-17(2H,10H,14H)-ylidene)-4-methylbenzenesulfonohydrazide
• 英文别名: 5alpha-Spirost-9(11)-en-3beta-ol,(25R); 5-dehydroepiandrosterone p-toluenesulfonyl hydrazone

物化性质

• 密度: 1.33g/cm3
• 沸点: 606.4ºC at 760mmHg
• 分子式: C₂₆H₃₆N₂O₃S
• 分子量: 456.64100
• 闪点: 320.5ºC
• 精确质量: 456.24500
• PSA: 87.14000
• LogP: 6.42470

合成路线

53-43-0 1576-35-8 ~97% 34988-34-6

文献：CRYSTAL PHARMA, S.A.U.; Perez Encabo, Alfonso; Turiel Hernandez, Jose Angel; Gallo Nieto, Francisco Javier; Lorente Bonde-Larsen, Antonio; Sandoval Rodriguez, Celso Miguel Patent: US2014/11992 A1, 2014 ; Location in patent: Paragraph 0201; 0202; 0203 ;

上下游产品

上游产品  2
53-43-0 1576-35-8
下游产品  1
154229-19-3